30 /100
MEDIUM RISK
Score updated May 30, 2026

CNTA — Centessa Pharmaceuticals plc Dilution Risk Tracker

Track CNTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CNTA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CNTA.
🔔 Track CNTA — Get forecast alerts →

💹 Market Data

Market Cap$6.15B
Shares Outstanding154.73M
Float92.48M
Cash$276.59M
Debt$118.56M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 88.63M shares
#1 Medicxi Ventures Management (Jersey) Ltd 19.96M shares
#2 Avoro Capital Advisors LLC 14.56M shares
#3 Adage Capital Partners GP L.L.C. 11.28M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest2.47M
Days to Cover2.2
% of Float2.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022
Form 4 INSIDER TRANSACTION Mar 26, 2026
Form 4 INSIDER TRANSACTION Mar 26, 2026
Form 4 INSIDER TRANSACTION Mar 17, 2026
Form 4 INSIDER TRANSACTION Mar 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CNTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CNTA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CNTA
📊 CNTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CNTA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.